Shares of the U.S. drugmaker have lost 11% of their value this year on worries over its growth after the pandemic as billions of dollars in COVID vaccine and treatment sales evaporated. Pfizer reiterated its annual revenue forecast of $8 billion from the sale of COVID-19 shot Comirnaty and anti-viral treatment Paxlovid. Revenue from Comirnaty, for which it partners with Germany's BioNTech, continues to perform consistently with its expectations, Pfizer said.
US interest rates are expected to stay on hold. Japan releases its latest
US interest rates are expected to stay on hold. Japan releases its latest
Golden State Equity Partners grew its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 134.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 25,493 shares of the biopharmaceutical company’s stock after purchasing an additional 14,607 shares during the quarter. Golden […]
Truist Financial Corp decreased its stake in Pfizer Inc. (NYSE:PFE – Free Report) by 17.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,303,487 shares of the biopharmaceutical company’s stock after selling 691,277 shares during the quarter. Truist Financial Corp’s holdings in […]
The agency greenlighted the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B.
Syon Capital LLC boosted its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 111.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 64,444 shares of the biopharmaceutical company’s stock after purchasing an additional 33,961 shares during […]
Ifrah Financial Services Inc. reduced its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 5.1% in the fourth quarter, HoldingsChannel reports. The firm owned 18,269 shares of the biopharmaceutical company’s stock after selling 984 shares during the period. Ifrah Financial Services Inc.’s holdings in Pfizer were worth $526,000 at the end of the most […]
Sales for Pfizer’s COVID-19 vaccine and oral treatment declined nearly 70% annually during the first quarter, underscoring the company’s earnings headaches as heads turned toward weight loss drugs.
According to information released by the Epoch Times, Pfizer purposefully failed to advise drug regulators, including Health Canada, the U.S. FDA and the European Medicines Agency, that the cancer-linked SV40 DNA enhancer was present in their experimental COVID shot.
Cutter & CO Brokerage Inc. increased its position in shares of Pfizer Inc. (NYSE:PFE – Free Report) by 473.4% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 104,331 shares of the biopharmaceutical company’s stock after purchasing an additional 86,137 shares during the […]
Reported Revenue: $14.9 billion, a decrease of 20% year-over-year, falling